AWAKE LM TT
Alternative Names: AWAKE-LM-TT; Listeria tetanus toxoid; Listeria TTLatest Information Update: 28 Jul 2024
At a glance
- Originator Loki Therapeutics
- Class Antineoplastics; Bacterial antigens; Bacterial toxins; Immunotherapies
- Mechanism of Action T lymphocyte stimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Phase I/II Pancreatic cancer
- Research Breast cancer; Colorectal cancer; Liver cancer; Lung cancer
- No development reported Ovarian cancer
Most Recent Events
- 28 Jul 2024 No recent reports of development identified for preclinical development in Ovarian-cancer in USA (Intraperitoneal, Injection)
- 11 Oct 2023 Early research in Breast cancer in USA (Parenteral) (Loki Therapeutics pipeline, October 2023)
- 11 Oct 2023 Early research in Colorectal cancer in USA (Parenteral) (Loki Therapeutics pipeline, October 2023)